Search research articles
Contact Us
Filters
Showing results (101-110 of 198) with videos related to
Page
of 20
Sort By:
Current Medicinal Chemistry
|
February 5, 2019
Cardioprotective Properties of HDL: Structural and Functional Considerations
Eleni Pappa, Moses S Elisaf, Christina Kostara, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 5, 2010
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering
Christos S Derdemezis, Theodosios D Filippatos, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design
|
January 16, 2013
Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias
Michael S Kostapanos, Evangelos C Rizos, Nikolaos Papanas, et al.
Current Vascular Pharmacology
|
February 15, 2011
Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation
Matilda Florentin, Evangelos N Liberopoulos, Anastazia Kei, et al.
Current Vascular Pharmacology
|
January 11, 2005
Fenofibrate: metabolic and pleiotropic effects
Vasilis Tsimihodimos, George Miltiadous, Stella S Daskalopoulou, et al.
Rheumatology International
|
September 1, 2005
Cryoglobulinemic purpura in visceral leishmaniasis
Evangelos Rizos, George Dimos, Evangelos N Liberopoulos, et al.
Journal of Clinical Pharmacology
|
September 5, 2003
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia
Haralampos J Milionis, John Papakostas, Anna Kakafika, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 16, 2010
Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L)
Evangelos N Liberopoulos, Matilda Florentin, Anastazia Kei, et al.
Current Vascular Pharmacology
|
April 17, 2019
Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
Rigas G Kalaitzidis, Thalia Panagiotopoulou, Dimitrios Stagikas, et al.
JAMA
|
September 13, 2012
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis
Evangelos C Rizos, Evangelia E Ntzani, Eftychia Bika, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 198) with videos related to
Sort By:
Page
of 20
Current Medicinal Chemistry
|
February 5, 2019
Cardioprotective Properties of HDL: Structural and Functional Considerations
Eleni Pappa, Moses S Elisaf, Christina Kostara, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
March 5, 2010
Review article: effects of plant sterols and stanols beyond low-density lipoprotein cholesterol lowering
Christos S Derdemezis, Theodosios D Filippatos, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design
|
January 16, 2013
Mitochondrial triglyceride transfer protein inhibition: new achievements in the treatment of dyslipidemias
Michael S Kostapanos, Evangelos C Rizos, Nikolaos Papanas, et al.
Current Vascular Pharmacology
|
February 15, 2011
Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation
Matilda Florentin, Evangelos N Liberopoulos, Anastazia Kei, et al.
Current Vascular Pharmacology
|
January 11, 2005
Fenofibrate: metabolic and pleiotropic effects
Vasilis Tsimihodimos, George Miltiadous, Stella S Daskalopoulou, et al.
Rheumatology International
|
September 1, 2005
Cryoglobulinemic purpura in visceral leishmaniasis
Evangelos Rizos, George Dimos, Evangelos N Liberopoulos, et al.
Journal of Clinical Pharmacology
|
September 5, 2003
Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia
Haralampos J Milionis, John Papakostas, Anna Kakafika, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
July 16, 2010
Comparison of hemoglobin A1c and fasting glucose criteria to diagnose diabetes among people with metabolic syndrome and fasting glucose above 100 mg/dL (5.5 mmol/L)
Evangelos N Liberopoulos, Matilda Florentin, Anastazia Kei, et al.
Current Vascular Pharmacology
|
April 17, 2019
Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
Rigas G Kalaitzidis, Thalia Panagiotopoulou, Dimitrios Stagikas, et al.
JAMA
|
September 13, 2012
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis
Evangelos C Rizos, Evangelia E Ntzani, Eftychia Bika, et al.
Page
of 20